Two individuals (MC 03 and MC 05) developed 1:6,400 anti-GnRH antibody titers; three individuals (MC01, MC 02, and MC 07) reached 1:3,200; two individuals (MC 04 and MC 06) developed 1:1,600 titers; and one patient (MC 08), developed 1:800 anti-GnRH antibody titers. were recorded and evaluated. The vaccine was well … Continue reading Two individuals (MC 03 and MC 05) developed 1:6,400 anti-GnRH antibody titers; three individuals (MC01, MC 02, and MC 07) reached 1:3,200; two individuals (MC 04 and MC 06) developed 1:1,600 titers; and one patient (MC 08), developed 1:800 anti-GnRH antibody titers